Evidence map›Paper›PMID 34924901›Full record

ArticleEXCLI journal2021

A case of xenon inhalation therapy for respiratory failure and neuropsychiatric disorders associated with COVID-19.

Vladimir Vasil'evich Udut, Sergei Alexandrovich Naumov, Diana Nikolaevna Evtushenko, Elena Vladimirovna Udut, Sergei Sergeevich Naumov, Gleb Nikolaevich Zyuz'kov

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in EXCLI journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Vladimir Vasil'evich UdutTomsk National Research Medical Center, Russian Academy of Sciences, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia.
Sergei Alexandrovich NaumovTomsk National Research Medical Center, Russian Academy of Sciences, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia.
Diana Nikolaevna EvtushenkoTomsk State University, Tomsk, Russia.
Elena Vladimirovna UdutTomsk National Research Medical Center, Russian Academy of Sciences, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia.
Sergei Sergeevich NaumovSiberian State Medical University, Tomsk, Russia.
Gleb Nikolaevich Zyuz'kovTomsk National Research Medical Center, Russian Academy of Sciences, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia.ORCID 0000-0003-0384-333X
Siberian State Medical University · RUNational Research Tomsk State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute respiratory distress syndrome (ARDS) is the main danger to the life of patients with pneumonia caused by SARS-CoV-2. At the same time, respiratory failure (RF) after ARDS can persist for a long time despite intensive therapy. Therefore, it is important to develop new effective approaches for restoring the ventilation function of the lungs after COVID-19. Here, we present a case report of effective application of short-term inhalations of xenon-oxygen (Xe/O

Indexed as

molecular modelingneuropsychiatric disordersrespiratory failureSARS-CoV-2surfactantxenon

Identifiers

PMID34924901
PMCPMC8678062
OpenAlexW3212684908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.